Asia Pacific Respiratory Therapeutic Devices Market information, By Devices (Nebulizers, Humidifiers, Oxygen Concentrators, Ventilators, Gas Analyzers, Capnographs, positive airway pressure (PAP), and others), by technology (Electrostatic Filtration, HEPA Filter, Hollow Fiber Filtration, Microsphere Separation and others) and by end user (Hospital and Homecare) - Forecast to 2030

Asia Pacific Respiratory Therapeutic Devices Market Overview

The Asia Pacific Respirtory Therapeutic Devices Market is projected to reach USD 2,400 Million by 2030 at 9.56% CAGR during the forecast period 2022-2030.Respiratory therapeutic devices are the instrument or the devices used to treat the respiratory diseases. These therapeutic devices are used in the treatment of chronic and acute respiratory diseases such as Asthma, COPD, tuberculosis and many more. Increasing population has increased the pollution and different air borne disease which has serve as a driving factor for the increase in the respiratory therapeutic devices market.

Different types of respiratory therapeutic devices are present in the market. Positive airway pressure (PAP) is the most famous and widely used device in the Asia Pacific region. While high cost of the product and lack of awareness about management of respiratory diseases can hamper the growth of the market.

In April 2024, Viemed Healthcare, Inc., a player in national respiratory care and home medical products and services with technology at its heart, made announcements of the completion of its strategic alliance with East Alabama Health that gave the company ownership control over East Alabama HomeMed, LLC. HomeMed supplies home medical equipment to patients within the EAH network as well as those in surrounding areas within Eastern Alabama.

In March 2024, Medline announced that it had acquired the manufacturing rights and intellectual property for AG Cuffill from Hospitech Respiration Ltd. The device is compact and it is designed like a syringe which makes it easy to measure pressure and volume contained in airway cuffs anywhere they are used in medicine.

In February 2024, Resmed unveiled its AirCurve 11 series devices -its newest line of bilevel devices that use two levels of support (inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP)) combined with digital technology to make treatment for sleep apnea more convenient for healthcare providers while also facilitating easier patient initiation on therapy.

Zephyr® Endobronchial Valve was approved by Pulmonx Corporation on November 2022 as per their announcement release. Pulmonx Corporation, which treats severe lung diseases through minimally invasive procedures globally acknowledged Zephyr® Endobronchial Valve approval granted to them in November 2022.

July 2022: Vivos Therapeutics was granted multiple Class I clearances by the Therapeutic Goods Administration for various indications such as snoring and obstructive sleep apnoea (mild, moderate, and severe) among adults and children on several oral appliances using this concept.

July 2022: OMRON Healthcare based in Japan has introduced portable oxygen concentrator targeting home care providers managing COPD’s therapeutic & lifestyle requirements.

For instance, CAIRE launched a portable oxygen concentrator in the U.S.-LifeStyle- in June 2022 to significantly enhance the lives of patients using oxygen across America.

For instance, Max Ventilators launched multifunctional noninvasive ventilators which come with inbuild oxygen therapy and humidifier for sale in India during May 2022.

Study Objectives of Asia Pacific Respiratory Therapeutic Devices Market:

• To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Asia Pacific Respiratory Therapeutic Devices market


• To provide the detail information about drivers and factors restraining the market growth.


• To analyze Asia Pacific Respiratory Therapeutic Devices Market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.


• To provide historical and forecast revenue of the market segments with respect to main geographies and their countries.


• To provide the trends and opportunities in respiratory therapeutic devices


• To provide country level analysis of the market with respect to the current market size and future prospective


• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

Regional Analysis

On regional basis Asia Pacific is segmented into Japan, China, India, Australia, Republic of Korea and Rest of Asia-Pacific. Increasing prevalence of diseases has increased the respiratory therapeutic device market. According to COPD foundation, it was estimated that 6.2% of total Asia Pacific population is suffering from COPD. And COPD will be the fifth leading cause for death till 2020. India has 30 million COPD patient while 8% of total china population is suffering from COPD due to increasing pollution.

Asia Pacific Respiratory Therapeutic Devices Market Segments

Asia Pacific Respiratory Therapeutic Devices market has been segmented on the basis of-

• By types of respiratory therapeutic devices used which includes- Nebulizers [Mechanical Nebulizer (Soft mist inhaler, Human powered nebulizer) and Electrical Nebulizer (Jet nebulizer, Ultrasonic wave Nebulizer and Other), Humidifiers (Bubble Humidifiers and Electrical Humidifier), Oxygen Concentrators (Continues Oxygen Concentrators and Portable Oxygen Concentrators), Ventilators (Volume-cycled ventilators, Pressure-cycled ventilators, Flow-cycled ventilators and other), Gas Analyzers, Capnographs, Positive airway pressure (Continuous Positive airway pressure, Automatic Positive airway pressure and Other ), Masks (Nasal Mask, Full Face Mask and Other) and others devices


• By technology used which includes Electrostatic Filtration, HEPA Filter, Hollow Fiber Filtration, Microsphere Separation and others


• By end user they are Hospital and Homecare


• By Countries they are Japan, China, India, Australia, Republic of Korea and Rest of Asia-Pacific.

Intended Audience

• Respiratory Therapeutic Devices Suppliers


• Respiratory Therapeutic Devices manufacturers


• Research and Development (R&D) Companies


• Hospitals and Laboratories


• Academic Medical Institutes and Universities